Financial Beings Research
Investment
The full Financial Beings investment research library — valuation frameworks, stock comparisons, dividend analysis, and long-term portfolio thinking across all sectors. Built for investors who prioritise business quality, realistic return expectations, and evidence-based decision-making over market noise.
-
Cenovus Energy ROA and ROE: A Complete Profitability Breakdown (2026)
Census (CVE) Valuation DeepdiveIf you have ever been burned by a stock that looked cheap and then cratered, you already understand Cenovus Energy. Here is what its…
-
Microsoft vs Adobe Stock: Which Is the Better Investment in 2026?
Find the better risk-reward stock.You’ll have two conflicting fears when weighing between Microsoft and Adobe: that you’re paying too much for the safe giant & that you’re getting…
-
AVGO vs QCOM: Which Stock Is the Better Buy in 2026?
Broadcom or Qualcomm? Which one is better priced?AVGO vs QCOM in 2026: Broadcom is the better business, but Qualcomm may be the better price. A valuation-led look at how much future…
-
ASML vs Broadcom (AVGO): Valuation, Backlogs & 2026 Outlook
ASML or Broadcom: Which one is a buy?The verdict. If you want it in one line: both are expensive, but ASML is the cheaper expensive one. On forward P/E, Broadcom looks…
-
JPM vs BAC 2026: Which Bank Is the Stronger Buy?
Read The Valuation Comparison!Both of America’s two largest banks have lost about 7% year-to-date in 2026, but they don’t sound much alike on the inside. JPMorgan Chase…
-
META vs NVDA: Which Stock Is the Real Gamble in 2026?
NVDA vs META: Find the right one!A Financial Beings Deep-Dive into Valuation, Risk & What Each Price Really Demands (2026) The two biggest companies on earth are side by side.…
-
Stock Picking vs Index Funds: Which is Better for Beginners in 2026?
Stocks vs Index Funds for InvestorsThat’s one number you shouldn’t ignore: 79% of all the large-cap fund managers who work in the industry missed the mark in 2025 on…
-
Is Dexcom (DXCM) a Good Stock to Buy Right Now in 2026? Complete Analysis & Outlook
Read Dexcom ValuationThe company nearly tripled its revenue, but Dexcom (NASDAQ: DXCM) is trading around $66.95 as of May 2026, approximately unchanged over the past five…
-
ETF vs ETP in 2026: What Every Investor Needs to Know
ETF vs ETP ComparisonYou finally decide to start investing. You open a brokerage account. You are looking for something easy and low-cost. Two terms appear immediately –…
-
Stocks vs ETFs: Side-by-Side Investment Comparison in 2026
Stocks vs ETFsOne of the most fundamental choices any investor must make is whether to invest in stocks or ETFs. They both trade on the same…
Flagship Analysis
Big Tech Valuation
Microsoft Expected Return Analysis 2026-2030
A strong anchor piece for understanding how Financial Beings frames growth, quality, and realistic long-term upside.